Jerash Holdings (US), Inc.

JRSH

CIK 0001696558 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$42M
↑+18.0% +$6Mvs FY2024 (Q4)
Operating Income
$2M
↑+174.5% +$1Mvs FY2024 (Q4)
Net Income
$1M
Gross Profit
$7M
↑+31.0% +$2Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
60/100
  • Profitability
    0ROIC 1.1% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 2.75 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    100Asset Turnover 1.79x (1.0+ = capital-efficient)
  • Growth
    77Revenue YoY +18.0% (10% = solid, 25%+ = elite)
  • Margin Trend
    81Op Margin 4.7% · trend +1.9pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project JRSH's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -59.0%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$0.47
Total enterprise IV
$6M
Diluted shares
0.01B
Terminal PV
$4M (70% of total)
Year-5 FCF
$479K
YearProjected FCFDiscounted PV
+1$426K$387K
+2$439K$363K
+3$452K$339K
+4$465K$318K
+5$479K$298K
Terminal$7M$4M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$1M
investment in PP&E
Dividends paid (TTM)
$3M
cash returned to holders
Stock buybacks (TTM)
share count reduction
Stock-based comp (TTM)
$1M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$84M
everything owned
Total liabilities
$21M
everything owed
Stockholders' equity
$64M
shareholder claim

Recent performance · 42 quarters

Revenue↑+18.0% +$6M
$42M
Net Income↑+20261.5% +$1M
$1M
Free Cash Flow↑+35.8% +$51K
$-92K
Operating Margin↑+2.7pts
4.7%

Drill down